Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 543

Results For "C"

10393 News Found

Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs
Biotech | May 25, 2023

Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs

The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets


Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS
Healthcare | May 24, 2023

Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS

5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience


Lonza launches TheraPEAK T-VIVO cell culture medium to accelerate cell therapy development
News | May 24, 2023

Lonza launches TheraPEAK T-VIVO cell culture medium to accelerate cell therapy development

Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing


Neutec introduces the oCelloscope automated microbial live-cell imaging technology
News | May 24, 2023

Neutec introduces the oCelloscope automated microbial live-cell imaging technology

The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development


Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi
Drug Approval | May 24, 2023

Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi

The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans


Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
News | May 24, 2023

Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr

The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023


Shilpa Medicare Analytical Services Division gets VAI status from USFDA after GMP inspection
Drug Approval | May 23, 2023

Shilpa Medicare Analytical Services Division gets VAI status from USFDA after GMP inspection

This is the second US FDA GMP inspection of this facility within one year


Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr
News | May 23, 2023

Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr

The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023


Agilent to appeal patent office decision on CRISPR gRNA patents
News | May 23, 2023

Agilent to appeal patent office decision on CRISPR gRNA patents

Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination


Freenome acquires global immunodiagnostics developer Oncimmune
News | May 23, 2023

Freenome acquires global immunodiagnostics developer Oncimmune

Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection